NIH-funded research R01 grant

Predicting early lung disease in children and young adults after stem cell transplant

Official title: Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11092102 · Data updated 2026-11-12

This work aims to find better ways to screen for and predict a serious lung condition called bronchiolitis obliterans syndrome (BOS) in children and young adults who have had a stem cell transplant.

More Transplant research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJuly 15, 2021
Project endApril 30, 2027
Funding year2025
Award (this year)$620,085
NIH project number5R01HL153108-05
Project IDNIH-11092102 on NIH RePORTER

Who could benefit from this research

Could help

This research is relevant for children and young adults who have received a hematopoietic stem cell transplant and are at risk for or have developed bronchiolitis obliterans syndrome.

Less likely to help

Patients who have not undergone a hematopoietic stem cell transplant or are not at risk for bronchiolitis obliterans syndrome would not directly benefit from this specific research.

What this research studies

Bronchiolitis obliterans syndrome (BOS) is a severe lung disease that can happen after a stem cell transplant, and it's often caught too late in children. Our goal is to develop new tools, like blood tests and prediction models, to find BOS much earlier. We will look at specific proteins in blood samples from both children and adults to see if they can predict who is at risk. This will help doctors make better treatment decisions and potentially prevent the disease from getting worse.

Why it matters

Potential benefit: If successful, this work could lead to earlier diagnosis and treatment for bronchiolitis obliterans syndrome, potentially improving survival and reducing long-term health problems for patients.

How similar studies have gone: This work is entirely novel, as there are currently no established biomarkers or predictive tools for bronchiolitis obliterans syndrome.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Myers, Kasiani — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Myers, Kasiani

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.